Hvis du har foretaget ændringer i Pure, vil de snart blive vist her.

Publikationer 1988 2019

Filtrer
Poster
2018

EUROPEAN POST-APPROVAL SAFETY STUDY IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SAFETY IN PATIENTS TREATED WITH POMALIDOMIDE IN A REAL-WORLD SETTING

Schmidt-Hieber, M., Abildgaard, N., Gamberi, B., Di Raimondo, F., Ramirez Payer, A., Kyriakou, C., Froen, H. F., Izarra, A. I., Kueenburg, E. ., Di Micco, A., Rosettani, B., Bacon, P., Atiba-Davies, M. & Plesner, T., 15. jun. 2018.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Inclusion body myositis and T cell large granular lymphocytic leucaemia: An underestimated coexistence of two severe disorders

Morillon, M., Iversen, K. F., korsgaard, S., Plesner, T. & Diederichsen, L. C. P. R., 1. sep. 2018.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Safety in Patients with Multiple Myeloma Treated with Pomalidomide in a Real-World Setting According to Last Prior Treatment: A European Post-Authorization Safety Study

Abildgaard, N., Vekemans, M-C., Gamberi, B., Di Raimondo, F., Ramirez Payer, A., Kyriakou, C., Kentos, A., Kueenburg, E. ., Di Micco, A., Rosettani, B., Bacon, P., Atiba-Davies, M. & Plesner, T., 2. dec. 2018.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

2017

FDG PET/CT in multiple myeloma: changed FDG uptake in the brain of patients receiving high dose chemotherapy

Østergaard, B., Shamchi, S. P., Taghvaei, R., Zirakchian, M. Z., Raynor, W., Nielsen, A. L., Holdgaard, P. C., Plesner, T., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 21. okt. 2017, s. 483-484.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

FDG-PET/CT in multiple myeloma: dual time point imaging results can predict response to treatment in patients recieving high dose chemotherapy

Østergaard, B., Taghvaei, R., Nielsen, A. L., Zirakchian, M. Z., Raynor, W., Asmussen, J. T., Holdgaard, P. C., Plesner, T., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 10. dec. 2017, s. 483. 1 s.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

Frailty Predicts Survival and Toxicity in Newly Diagnosed Multiple Myeloma Patients Ineligible for Autologous Stem Cell Transplantation; Report of the HOVON-87/Nmsg-18 Study Group

Stege, C. A. M., Sonneveld, P., Plesner, T., Stevens-Kroef, M., van der Holt, B., Zweegman, S., Waage, A., Klein, S., Sinnige, H., Mellqvist, U-H., Abildgaard, N., Durian, M. F., Hansson, M., Levin, M-D., Leijs, M. B., Szatkowski, D. L., Haukås, E., Salomo, M., Bos, G., Visser-Wisselaar, H. & 11 flere, van der Velden, A., Deenik, W., Gruber, A., Coenen, J. L. L. M., Tanis, B., Brouwer, R., Westerman, M., van der Hem, K., Mattijssen, V., Gimsing, P. & Van De Donk, N. WCJ., 10. dec. 2017.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

2016

18F-FDG-PET/CT in Multiple Myeloma: High Intense PET Positive Lesions at Diagnosis Harbor Cytogenetic Adverse Subclones

Østergaard, B., Nielsen, A. L., Møller, H. E. H., Preiss, B. S., Asmussen, J. T., Mortensen, J. R., Plesner, T., Gerke, O., Alavi, A., Høilund-Carlsen, P. F. & Abildgaard, N., 2016.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

FDG-PET/CT in multiple myeloma: Correlation between SUV and standard prognostic scoring system in multiple myeloma

Østergaard, B., Nielsen, A. L., Gerke, O., Mortensen, J. R., Asmussen, J. T., Plesner, T., Ormstrup, TE., Holdgaard, P. C., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 2016.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Findings of Whole Body Computed Tomography Compared to Conventional Skeletal Survey in Patients with Monoclonal Plasma Cell Disorders – a Study of the International Myeloma Working Group

Hillengass, J., Monopoulos, L. A., Delorme, S., Koutoulidis, V., Hielscher, T., Engelhart, J., Drake, M. T., Rajkumar, V., Østergaard, B., Abildgaard, N., Hinge, M., Plesner, T., Suehara, Y. S., Matsue, K., Caers, J., Withofs, N., Dimopoulos1, M., Goldschmidt, H., Lentzsch, S., Durie, B. G. & 1 flere, Terpos, E., 2016.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Improvement of overall survival in Danish Multiple Myeloma patients after 2008; a population-based study from the Danish National Multiple Myeloma Registry

Abildgaard, N., Vangsted, A., Gregersen, H., Niels Frost, A., Pedersen, R. S., Plesner, T., Trøllund Pedersen, P., Frederiksen, M., Frølund, U., Helleberg, C., Salomo, M., Holmström, M., Klausen, T. W. & Gimsing, P., 9. jun. 2016.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

2015

Continued improvement in overall survival in elderly multiple myeloma patients after 2008; a population based study from the Danish Multiple Myeloma Registry

Abildgaard, N., Vangsted, A., Gregersen, H., Pedersen, R. S., Plesner, T., Trøllund Pedersen, P., Frederiksen, M., Frølund, U., Helleberg, C., Klausen, T. W. & Gimsing, P., 23. sep. 2015.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

CT is superior to X-ray in diagnosing osteolytic lesions in the spine and pelvis: A prospective study of newly diagnosed multiple myeloma patients. European Hematology Association.2015 E1249

Hinge, M., Andersen, K. T., Lund, T., Boel-Jørgensen, H., Holdgaard, P., Ormstrup, T., Lange Østergaard, L. & Plesner, T., 11. jun. 2015.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

First-line treatment with doxorubicin, cyclophosphamide, bortezomib, dexamethasone and lenalidomide (ACVDL) in patients with multiple myeloma. ICPOEP 2015

Andersen, K. T., Hinge, M., Segel, E. K., Ormstrup, T., Holdgaard, P., Pallisgaard, N., Kerndrup, G. B. & Plesner, T., nov. 2015.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Safety and efficacy of first-line treatment with doxorubicin, cyclophosphamide, bortezomib, dexamethasone and lenalidomide (ACVDL) in newly diagnosed multiple myeloma patients of all ages. IMW 2015, PO-112

Andersen, K. T., Hinge, M., Segel, E. K., Ormstrup, T., Holdgaard, P., Boel-Jørgensen, H., Pallisgaard, N., Kerndrup, G. B. & Plesner, T., sep. 2015.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

2014

Safety and efficacy of daratumumab with lenalidomide and dexamethasone in relapsed or relapsed, refractory multiple myeloma

Plesner, T., Arkenau, H-T., Lokhorst, H. M., Gimsing, P., Krejcik, J., Rose Lemech, C., Minnema, M., Lassen, U. N., Ahmadi, T., Yeh, H., Guckert, M., C. Brun, N., Lisby, S., Basse, L., Palumbo, A. & Richardson, P., 2014.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

"Is zoledronic acid retention onto bone different in multiple myeloma and breast cancer patients with bone metastasis?" in Journal of Bone and Mineral Research, 27, suppl. 1, p323

Søe, K., Plesner, T., Hugger Jakobsen, E., Hansen, CT., Jørgensen, H. & Delaissé, J-M., 2012. 1 s.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

2011

A Phase I/II, Dose-Escalation Study of Daratumumab, A CD38 Mab in Patients with Multiple Myeloma Preliminary Safety Data

Gimsing, P., Plesner, T., Nahi, H., Lokhorst, H., Valentin, M-L., Lisby, S. & Richardson, PG., 8. dec. 2011.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

2009

Combined bonemarkers give unique information in myeloma

Lund, T., Hamid, R., Christensen, J. H., Levin Andersen, T., Abildgaard, N., Delaissé, J-M. & Plesner, T., 2009.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

Inclusion of myeloma cell nuclei in osteoclasts activates their resorptive activity

Kupisiewicz, K., Levin Andersen, T., Lund, T., Kerndrup, G. B., Preiss, B., Plesner, T., Abildgaard, N. & Delaissé, J-M., 2009.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

Rapid stimulation of bone formation by Bortezomib in multiple myeloma

Lund, T., Søe, K., Abildgaard, N., Garnero, P., Pedersen, PT., Delaissé, J-M. & Plesner, T., 2009.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

The proteasome inhibitor bortezomib overcomes the inhibition of osteoblast function observed in multiple myeloma

Lund, T., Søe, K., Abildgaard, N., Garnero, P., Pedersen, PT., Ormstrup, T., Delaissé, J-M. & Plesner, T., 2009.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

2008

A physical mechanism for coupling bone resorption and formation in adult human bone

Levin Andersen, T., Søndergaard, T. E., Skorzynska, K., Plesner, TL., Plesner, T., Hauge, E. & Delaissé, J-M., 2008.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

Biological prerequisites for heterotypic fusion between myeloma cells and osteoclasts

Kupisiewicz, K., Søe, K., Levin Andersen, T., Søndergaard, T. E., Plesner, T. & Delaissé, J-M., 2008.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Resveratrol analogs as potential treatment of multiple myeloma and bone related disease: Effect on myeloma cells and osteoclasts in vitro

Kupisiewicz, K., Boissy, P., Søe, K., Plesner, T. & Delaissé, J-M., 2008.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

The bone degradation marker CTX is a unique marker for disease progression in multiple myeloma

Lund, T., Delaissé, J-M., Abildgaard, N., Kupisiewicz, K. & Plesner, T., 2008.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

The bone degradation marker CTX shows unique properties in disease monitoring compared to NTX, ICTP and bALP in multiple myeloma

Lund, T., Delaissé, J-M., Abildgaard, N., Kupisiewicz, K., Levin Andersen, T., Søe, K. & Plesner, T., 2008.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Cells of the myeloma clone directly contribute to the formation of osteoclasts in myeloma patients

Levin Andersen, T., Søndergaard, T. E., Kupisiewicz, K., Plesner, T., Kølvrå, S. & Delaissé, J-M., 2007.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

Identification of a highly specialized micro-anatomical structure that is a key player in myeloma bone disease

Levin Andersen, T., Søndergaard, T. E., Boissy, P., Skorzynska, EK., Plesner, TL., Hauge, E., Plesner, T. & Delaissé, J-M., 2007.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

Intermittent treatment with bortezomib inhibits transiently osteoclast resorptive activity

Boissy, P., Lund, T., Levin Andersen, T., Plesner, T. & Delaissé, J-M., 2007.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

Lymphocytic cells from the myeloma B-cell clone contribute to the formation of osteoclasts in myeloma patients

Levin Andersen, T., Boissy, P., Søndergaard, T. E., Kupisiewicz, K., Plesner, T., Rasmussen, T., Christensen, J. H., Kølvrå, S. & Delaissé, J-M., 2007.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

Resveratrol analogs as potential treatment of multiple myeloma and bone related disease: Effect on myeloma cells, osteoclasts and osteoblasts in vitro

Kupisiewicz, K., Boissy, P., Søe, K., Abdallah, B., Kassem, M., Plesner, T. & Delaissé, J-M., 2007.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

Resveratrol and its analogs for treating multiple myeloma

Kupisiewicz, K., Boissy, P., Søe, K., Abdallah, B., Kassem, M., Plesner, T. & Delaissé, J-M., 2007.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning